Almanac Health launches AI teammate for physicians to improve care

Summary

Almanac Health has launched an AI-powered teammate for physicians designed to alleviate clinical administrative burdens, improving healthcare delivery by managing tasks such as documentation and research. This initiative, called Almanac, integrates seamlessly with electronic health records and is built on a foundation of peer-reviewed research to ensure reliability. The company has successfully raised a total of $12 million in funding, including a $2 million pre-seed round and a $10 million seed round, aimed at enhancing physician workflows and giving them more time for patient care.

Analysis

Cyril Zakka: Cyril Zakka, MD, is a physician-researcher, founder, and CEO of Almanac Health with a background in clinical practice, Stanford machine learning research, and health AI at Hugging Face. His prior work pioneered retrieval-augmented generation approaches for clinical medicine. In the news, he is quoted explaining the company's focus on addressing time scarcity in healthcare through the Almanac platform. Almanac Health: Almanac Health is a research-validated clinical AI platform and evidence-based clinical decision support company founded by physician-researcher Cyril Zakka, MD. It develops tools that integrate with existing electronic health record systems and are grounded in peer-reviewed evidence rather than promotional content. In the news, the company is launching its Almanac collaborative agent to handle multi-step clinical tasks, research retrieval, and documentation, freeing physicians for direct patient care. FPrime Capital: F-Prime Capital is a venture capital firm specializing in healthcare and life sciences investments. It led Almanac Health's recent seed round. In the news, the firm backs the company's launch of its research-validated clinical AI platform for physicians. General Catalyst: General Catalyst is a global venture capital and transformation firm that partners with entrepreneurs to build resilient, AI-driven companies across sectors including healthcare. It previously led Almanac Health's pre-seed round. In the news, the firm is an investor in the company's seed financing and supports its mission to integrate trusted AI into clinical workflows. Lightspeed Venture Partners: Lightspeed Venture Partners is a multi-stage venture capital firm focused on disruptive innovations in enterprise, health, consumer, and fintech sectors. It participated in Almanac Health's seed round alongside other investors. In the news, the firm supports the company's efforts to deliver evidence-based AI tools that integrate with clinicians' existing workspaces. Clinical AI Focus: Almanac Health emphasizes platforms grounded in peer-reviewed research and institutional governance rather than unverified data or commercial promotion. Healthcare AI Validation: The platform is currently undergoing rigorous clinical validation in academic medical center settings to ensure safety and reliability for point-of-care use. Physician Workflow Integration: The launched Almanac agent is designed to operate directly within electronic health records and workspaces to delegate tasks and support evidence retrieval across specialties.

Categories

machine_learningaiai_agentstech

Related sources

View Original Tweet